A new study has claimed that having diabetes could heighten the chances of the recurrence of bladder cancer, as well as promoting its progression. The research argued that diabetes could be an independent predictor of non-muscle invasive bladder cancer (NMIBC) recurring or progressing. The study which involved 251 patients found that those who had diabetes when being treated for this form of bladder cancer faced a twofold increased risk of the disease recurring, and a ninefold increased risk of it progressing as compared with those patients who did not suffer from diabetes. It was also revealed that the diabetes patients tended to be older and have a higher rate of hypertension than the participants without diabetes. In addition, the patients with high A1c levels experienced a substantially greater risk of multiple tumors and had a lot more intravesical therapy carried out. International Journal of Urology Nov. 2011
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.